Study to Investigate the Effect of PBF-680 on Forced Expiratory Volume in 1 Second (FEV1) in Asthmatic Patients
Status:
Completed
Trial end date:
2020-03-16
Target enrollment:
Participant gender:
Summary
The present trial is an exploratory study aiming at evaluating the safety, tolerability, and
efficacy of a 15-day, once daily administration of 10 mg PBF-680 in subjects with persistent,
mild-to-moderate atopic asthma.